BACE1 SUMOylation deregulates phosphorylation and ubiquitination in Alzheimer's disease pathology
Journal of Neurochemistry · 2023
DOI: 10.1111/jnc.15870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, 2023. Verfasst von Yanna Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Biomedical Sciences, School of Medicine, Jianghan University, Wuhan, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid Precursor Protein Secretases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Themen: Demenz
Abstract (Originalsprache)
BACE1 is essential for the generation of amyloid‐β (Aβ) that likely initiates the toxicity in Alzheimer's disease (AD). BACE1 activity is mainly regulated by post‐translational modifications, but the relationship between these modifications is not fully characterized. Here, we studied the effects of BACE1 SUMOylation on its phosphorylation and ubiquitination. We demonstrate that SUMOylation of BACE1 inhibits its phosphorylation at S498 and its ubiquitination in vitro. Conversely, BACE1 phosphorylation at S498 suppresses its SUMOylation, which results in promoting BACE1 degradation in vitro. Furthermore, an increase in BACE1 SUMOylation is associated with the progression of AD pathology, while its phosphorylation and ubiquitination are decreased in an AD mouse model. Our findings suggest that BACE1 SUMOylation reciprocally influences its phosphorylation and competes against its ubiquitination, which might provide a new insight into the regulations of BACE1 activity and Aβ accumulation. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institutes of Biomedical Sciences, School of Medicine, Jianghan University, Wuhan, China.
- Department of Pathology and Pathophysiology, School of Medicine, Jianghan University, Wuhan, China.
- Department of Physiology, School of Medicine, Jianghan University, Wuhan, China.
- Department of Pathophysiology, School of Basic Medicine, Key Laboratory of Education Ministry of China for Neurological Disorders, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Yifan Xiao, Jian Bao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
Zitieren
APA
Zhao, Y., Zhou, H., Zhao, Y., Liang, Z., Gong, X., Yu, J., Huang, T., Yang, C., Wu, M., Xiao, Y., Yang, Y., Liu, W., Wang, X., Shu, X., & Bao, J. (2023). BACE1 SUMOylation deregulates phosphorylation and ubiquitination in Alzheimer's disease pathology. Journal of Neurochemistry. https://doi.org/10.1111/jnc.15870
Vancouver
Zhao Y, Zhou H, Zhao Y, Liang Z, Gong X, Yu J, et al. BACE1 SUMOylation deregulates phosphorylation and ubiquitination in Alzheimer's disease pathology. Journal of Neurochemistry. 2023. doi:10.1111/jnc.15870
BibTeX
@article{Zhao2023,
author = {Zhao, Yanna and Zhou, Hongyan and Zhao, Yan and Liang, Zhen and Gong, Xiaokang and Yu, Jing and Huang, Tiantian and Yang, Chaoqin and Wu, Mengjuan and Xiao, Yifan and Yang, Youhua and Liu, Wei and Wang, Xiaochuan and Shu, Xiji and Bao, Jian},
title = {BACE1 SUMOylation deregulates phosphorylation and ubiquitination in Alzheimer's disease pathology},
journal = {Journal of Neurochemistry},
year = {2023},
doi = {10.1111/jnc.15870}
}
EUVIMED